Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
2013 Standout
Thiazolidinediones
2004 Standout
Effect of lipid reduction on the progression of renal disease: A meta-analysis
2001
Inner retinal ischaemia: current understanding and needs for further investigations
2009
Progression of nephropathy in type 2 diabetic patients
2004
Diabetic retinopathy
2010 Standout
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study
1996
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
1997
Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction
2004 Standout
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
Diabetic renal disease: from recent studies to improved clinical practice
2004
The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
2001 Standout
The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men
2002 Standout
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
2011 Standout
The metabolic syndrome
2010 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
Metabolic syndrome and renal sodium handling in three ethnic groups living in England
2004
Renal handling of albumin: A critical review of basic concepts and perspective
2002
Retinal Vascular Lesions in Patients of Caucasian and Asian Origin With Type 2 Diabetes
2008
Microalbuminuria: Definition, Detection, and Clinical Significance
2004
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
2004 Standout
Renal Insufficiency in the Absence of Albuminuria and Retinopathy Among Adults With Type 2 Diabetes Mellitus
2003
A Molecular Signature of Proteinuria in Glomerulonephritis
2010
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
2006 Standout
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study
1997
Impact of sleep debt on metabolic and endocrine function
1999 Standout
Diabetic Retinopathy
2012 Standout
Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial
2007
The metabolic syndrome
2005 Standout
Diabetic retinopathy and systemic vascular complications
2007
The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals
2004
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Relation between albumin in the urine and electrocardiographic markers of myocardial ischemia in patients without diabetes mellitus
2001
Endothelial dysfunction and pathogenesis of diabetic angiopathy
1997
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
2007
Metformin
1996
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study
2000
The Effects of Improved Glycemic Control on Complications in Type 2 Diabetes
1998
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Rosiglitazone reduces urinary albumin excretion in type II diabetes
2003
Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance
1998
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
1998
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
Hypertension and Associated Metabolic Abnormalities — The Role of Insulin Resistance and the Sympathoadrenal System
1996
Usefulness of Microalbuminuria in Predicting Cardiovascular Mortality in Treated Hypertensive Men With and Without Diabetes Mellitus
1997
Glycemic control and cardiovascular disease in Type 2 diabetes: a review
1999
Understanding the nature of renal disease progression
1997
The Hallmarks of Aging
2013 Standout
Proteinuria as a risk factor for cardiovascular disease and mortality in older people: a prospective study
2000
Prevalence of Chronic Kidney Disease in the United States
2007 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Morbidity in 565 Type 2 Diabetic Patients According to Stage of Nephropathy
1998
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Chronic Kidney Disease
2016 Standout
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Epidemiological Evidence for the Association of Hyperglycaemia and Atherosclerotic Vascular Disease in Non-insulin-dependent Diabetes Mellitus
1996
Nephropathy in Patients with Type 2 Diabetes Mellitus
1999
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Fatty Acid Composition of Serum Lipid Fractions in Type 2 Diabetic Patients With Microalbuminuria
2003
The Risk of Cardiovascular Disease Mortality Associated With Microalbuminuria and Gross Proteinuria in Persons With Older-Onset Diabetes Mellitus
2000
Introducing MINA – The Molecularly Imprinted Nanoparticle Assay
2014
Treatment of Cardiovascular and Renal Risk Factors in the Diabetic Hypertensive
2002
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
A Diabetes Outcome Progression Trial (ADOPT)
2002
Safety and Efficacy of Repaglinide in Type 2 Diabetic Patients With and Without Impaired Renal Function
2003
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
2004 Standout
Microalbuminuria and Peripheral Arterial Disease Are Independent Predictors of Cardiovascular and All-Cause Mortality, Especially Among Hypertensive Subjects
1999
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis.
1993
Inflammatory, Hemostatic, and Other Novel Biomarkers for Diabetic Retinopathy
2009
Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis
2016 Standout
Type 2-diabetes og det metaboliske syndrom - diagnostik og behandling
2000
Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease
2012
Multifunctional Au Nanoparticle Dendrimer-Based Surface Plasmon Resonance Biosensor and Its Application for Improved Insulin Detection
2010
Intensive Integrated Therapy of Type 2 Diabetes
2004
Left ventricular mass index increases in proportion to the progression of diabetic nephropathy in Type 2 diabetic patients
2001
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study
1999
Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease
2000
Why the kidney glomerulus does not clog: A gel permeation/diffusion hypothesis of renal function
2003 StandoutNobel
Flicker Light–Induced Retinal Vasodilation in Diabetes and Diabetic Retinopathy
2009
Prevalence of Arterial Hypertension in Diabetic Patients Before and After the JNC-V
1994
Microalbuminuria and Carotid Artery Intima-Media Thickness in Nondiabetic and NIDDM Subjects
1997
Glomerular structure and function in proteinuric Type 2 (non-insulin-dependent) diabetic patients
1993
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
2000
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
2003 Standout
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
Increased Urinary Albumin Excretion, Endothelial Dysfunction, and Chronic Low-Grade Inflammation in Type 2 Diabetes
2002
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis
2010 Standout
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
1999 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Proteinuria Predicts Stroke and Other Atherosclerotic Vascular Disease Events in Nondiabetic and Non–Insulin-Dependent Diabetic Subjects
1996
Urinary Albumin Excretion Rate and Glomerular Filtration Rate in Single-Kidney Type 2 Diabetic Patients
1998
Works of M.‐A. Gall being referenced
The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy
1993
Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients
1991
Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy
1996
Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes
2004
Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy
1992
Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials
2015
Glomerular size-and charge selectivity in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy
1994
Endothelial dysfunction and low‐grade inflammation and the progression of retinopathy in Type 2 diabetes
2007
Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations
2009
Effect of insulin on renal sodium handling in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetic patients with peripheral insulin resistance
1991
Albuminuria and poor glycemic control predict mortality in NIDDM
1995